2010
DOI: 10.1016/j.oraloncology.2010.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Paradigm shifts in the management of osteoradionecrosis of the mandible

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
177
1
12

Year Published

2014
2014
2024
2024

Publication Types

Select...
5
2

Relationship

0
7

Authors

Journals

citations
Cited by 174 publications
(191 citation statements)
references
References 38 publications
1
177
1
12
Order By: Relevance
“…If there was an orocutaneous fistula, or large soft tissue loss, primary closure or softtissue reconstruction is accomplished during this surgery. HBOT is continued for another 10 treatments [5][6][7].…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…If there was an orocutaneous fistula, or large soft tissue loss, primary closure or softtissue reconstruction is accomplished during this surgery. HBOT is continued for another 10 treatments [5][6][7].…”
Section: Discussionmentioning
confidence: 99%
“…Its muscle tissue is considered particularly resistant to infection and plate exerted pressure [17]. When a free tissue transfer is not feasible, a viable treatment option supported by many authors is the use of the PMMC flap wrapped around an AO reconstruction plate for mandibular reconstruction to precisely bridge the mandibular defects [7,[17][18][19][20]. Ease of its application allows a relatively rapid and simple reconstructive option, especially in advanced or palliative cases or where the general condition of the patient does not allow for an extensive microvascular free flap transfer procedure [21].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…[5].Intensity Modulated Radiotherapy (IMRT), brachytherapy, helical tomotherapy could be the next advance in reducing rate of ORN. [6,7] Diseased tooth extractions (odontogenic and periodontal disease), denture trauma after irradiation, [8] abuse of alcohol and tobacco are also considered as risk factors for ORN. [6,9] Other factors associated with ORN are location of primary tumor in tongue, floor of mouth, alveolar ridge, reteromolar trigone, tonsil, stage III/IV cancer, doses above 60Gy of radiation, poor nutritional status which could affect wound healing.…”
Section: Discussionmentioning
confidence: 99%
“…The replacement of the dead bone with a vascularised bone-containing flap will allow for restoration of the mandibular continuity and provide non irradiated soft-tissue coverage with blood supply. [6,8] There are other novel innovations in management of ORN which are 1200 mg/d pentoxifylline (PTX) for 6 months, combination of PTX and tocopherol (vitamin E). PTX is an antioxidant methylxanthine derivative with an anti-tumor necrosis factor effect.…”
Section: Discussionmentioning
confidence: 99%